Research programme: AMPA receptor modulators - Boehringer
Alternative Names: BIIR 777Latest Information Update: 16 Jul 2016
At a glance
- Originator Boehringer Ingelheim
- Class
- Mechanism of Action Neurotransmitter receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders; Memory disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in Germany (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Memory disorders in Germany (PO)
- 02 Nov 2006 Preclinical trials in Cognition disorders in Germany (PO)